CD105 is a more appropriate marker for evaluating angiogenesis in urothelial cancer of the upper urinary tract than CD31 or CD34.

Virchows Arch · 2013 · PMC3825622 · PMID 23975255

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

This is contested by other reports, e.g., in cervical cancer, with high CD31-MVD predicting progression-free survival and overall survival, whereas high CD105-MVD only showed a trend for worse survival [ 11 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.